| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Achievement of recommended lipid and lipoprotein levels with combined ezetimibe/statin therapy versus statin alone in patients with and without diabetes
|
Guyton, John R
|
|
2011
|
|
2 |
p. 160-172
|
artikel
|
| 2 |
A commentary on Diabetic and non-diabetic patients with left main and/ or three-vessel coronary artery disease: Comparison of outcomes with cardiac surgery and paclitaxel-eluting stents by Banning AP et al*
|
Marx, Nikolaus
|
|
2011
|
|
2 |
p. 173-173
|
artikel
|
| 3 |
Acute glucose dysmetabolism in the early phase of ST-elevation myocardial infarction: the age response
|
Lazzeri, Chiara
|
|
2010
|
|
2 |
p. 131-137
|
artikel
|
| 4 |
Adherence to vascular protection drugs in diabetic patients in Quebec: a population-based analysis
|
Asghari, Shabnam
|
|
2010
|
|
2 |
p. 167-171
|
artikel
|
| 5 |
A genetic variant regulating miR-126 is associated with sight threatening diabetic retinopathy
|
McAuley, Annie K
|
|
2015
|
|
2 |
p. 133-138
|
artikel
|
| 6 |
A GLP-1 receptor agonist liraglutide inhibits endothelial cell dysfunction and vascular adhesion molecule expression in an ApoE-/- mouse model
|
Gaspari, Tracey
|
|
2011
|
|
2 |
p. 117-124
|
artikel
|
| 7 |
A gluco-metabolic risk index with cardiovascular risk stratification potential in patients with coronary artery disease
|
Anselmino, Matteo
|
|
2009
|
|
2 |
p. 62-70
|
artikel
|
| 8 |
Aleglitazar, a dual peroxisome proliferator-activated receptor-α and -γ agonist, protects cardiomyocytes against the adverse effects of hyperglycaemia
|
Chen, Yan
|
|
2017
|
|
2 |
p. 152-162
|
artikel
|
| 9 |
An analysis of barriers to entry of cardiac rehabilitation in patients with diabetes: Using data from the National Audit of Cardiac Rehabilitation
|
Harrison, Alexander S
|
|
2018
|
|
2 |
p. 145-149
|
artikel
|
| 10 |
Apo-B/AI ratio identifies cardiovascular risk in childhood:The Australian Aboriginal Birth Cohort study
|
Sellers, Elizabeth A.C.
|
|
2009
|
|
2 |
p. 94-99
|
artikel
|
| 11 |
Assessment of cardiac structure and function in patients without and with peripheral oedema during rosiglitazone treatment
|
Narang, Nikhil
|
|
2011
|
|
2 |
p. 101-108
|
artikel
|
| 12 |
Association of glucagon-to-insulin ratio and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus
|
Moh Moh, Myint Aung
|
|
2019
|
|
2 |
p. 186-195
|
artikel
|
| 13 |
Association of retinopathy with coronary atherosclerosis determined by coronary 64-slice multidetector computed tomography angiography in type 2 diabetes
|
Rong, Jian
|
|
2013
|
|
2 |
p. 161-168
|
artikel
|
| 14 |
Bariatric surgery as a model to explore the basis and consequences of the Reaven hypothesis: Small, dense low-density lipoprotein and interleukin-6
|
Adam, Safwaan
|
|
2019
|
|
2 |
p. 144-152
|
artikel
|
| 15 |
Baseline fasting plasma insulin levels predict risk for major adverse cardiovascular events among patients with diabetes and high-risk vascular disease: Insights from the ACCELERATE trial
|
Kumar, Anirudh
|
|
2019
|
|
2 |
p. 171-177
|
artikel
|
| 16 |
Body mapping of human cutaneous microcirculatory perfusion using a real-time laser Doppler imager
|
Harbi, Pascal
|
|
2013
|
|
2 |
p. 187-190
|
artikel
|
| 17 |
Cardiovascular effects of the DPP-4 inhibitors
|
Jose, Tessey
|
|
2012
|
|
2 |
p. 109-116
|
artikel
|
| 18 |
Cardiovascular trials and diabetes treatments: A regulatory maze
|
Matthews, David R
|
|
2012
|
|
2 |
p. 83-84
|
artikel
|
| 19 |
CD40–CD40L: Linking pancreatic, adipose tissue and vascular inflammation in type 2 diabetes and its complications
|
Seijkens, Tom
|
|
2013
|
|
2 |
p. 115-122
|
artikel
|
| 20 |
Charting weight four times daily as an effective behavioural approach to obesity in patients with type 2 diabetes
|
Yamada, Tomohide
|
|
2014
|
|
2 |
p. 118-120
|
artikel
|
| 21 |
Coadministration of muraglitazar plus glyburide: Improvement of glycaemic and lipid profiles in patients with type 2 diabetes
|
Rubin, Cindy J.
|
|
2009
|
|
2 |
p. 120-132
|
artikel
|
| 22 |
Combined serum free light chain levels are associated with carotid atherosclerosis in type 2 diabetes mellitus
|
Aberer, Felix
|
|
2018
|
|
2 |
p. 162-164
|
artikel
|
| 23 |
Comparison between surrogate indices of insulin sensitivity and resistance, and the hyperinsulinaemic euglycaemic glucose clamp in urban South African blacks with and without coronary artery disease
|
Ntyintyane, Lucas
|
|
2010
|
|
2 |
p. 151-157
|
artikel
|
| 24 |
Copeptin in patients with acute myocardial infarction and newly detected glucose abnormalities – A marker of increased stress susceptibility? A report from the Glucose in Acute Myocardial Infarction cohort
|
Smaradottir, Maria Isabel
|
|
2017
|
|
2 |
p. 69-76
|
artikel
|
| 25 |
Development of sotagliflozin, a dual sodium-dependent glucose transporter 1/2 inhibitor
|
Lapuerta, Pablo
|
|
2015
|
|
2 |
p. 101-110
|
artikel
|
| 26 |
Diabetes and Vascular Disease Research: A new beginning
|
Grant, Peter J.
|
|
2009
|
|
2 |
p. 61-61
|
artikel
|
| 27 |
Dipeptidyl peptidase-4 inhibitor reduces infarct size and preserves cardiac function via mitochondrial protection in ischaemia–reperfusion rat heart
|
Chinda, Kroekkiat
|
|
2014
|
|
2 |
p. 75-83
|
artikel
|
| 28 |
Drugs for type 2 diabetes mellitus: The imperative for cardiovascular outcome assessment
|
Gore, M Odette
|
|
2012
|
|
2 |
p. 85-88
|
artikel
|
| 29 |
Early stage detection of conduit artery endothelial dysfunction in patients with type 1 diabetes
|
Bellien, Jeremy
|
|
2010
|
|
2 |
p. 158-166
|
artikel
|
| 30 |
Effect of bariatric surgery on diabetic nephropathy in obese type 2 diabetes patients in a retrospective 2-year study: A local pilot
|
Chao, Anthony TL
|
|
2018
|
|
2 |
p. 139-144
|
artikel
|
| 31 |
Effect of treatment with rosiglitazone on high-sensitivity cardiac troponin levels among patients with type 2 diabetes mellitus
|
Salahuddin, Usman I
|
|
2016
|
|
2 |
p. 113-118
|
artikel
|
| 32 |
Effects of an adapted cardiac rehabilitation programme on arterial stiffness in patients with type 2 diabetes without cardiac disease diagnosis
|
Brozic, Anka P
|
|
2017
|
|
2 |
p. 104-112
|
artikel
|
| 33 |
Effects of magnitude of visceral adipose tissue reduction: Impact on insulin resistance, hyperleptinemia and cardiometabolic risk in adolescents with obesity after long-term weight-loss therapy
|
Campos, Raquel Munhoz da Silveira
|
|
2019
|
|
2 |
p. 196-206
|
artikel
|
| 34 |
Effects of obesity on insulin: insulin-like growth factor 1 hybrid receptor expression and Akt phosphorylation in conduit and resistance arteries
|
Mughal, Romana S
|
|
2019
|
|
2 |
p. 160-170
|
artikel
|
| 35 |
Effects of SGLT2 inhibitors on cardiovascular outcomes
|
Foote, Celine
|
|
2012
|
|
2 |
p. 117-123
|
artikel
|
| 36 |
Elevated levels of adipokines predict outcome after acute myocardial infarction: A long-term follow-up of the Glucose Tolerance in Patients with Acute Myocardial Infarction cohort
|
Ritsinger, Viveca
|
|
2017
|
|
2 |
p. 77-87
|
artikel
|
| 37 |
Elevated serum glucose levels and survival after acute heart failure: A population-based perspective
|
Helfand, Benjamin KI
|
|
2015
|
|
2 |
p. 119-125
|
artikel
|
| 38 |
Empagliflozin reduces body weight and indices of adipose distribution in patients with type 2 diabetes mellitus
|
Neeland, Ian J
|
|
2016
|
|
2 |
p. 119-126
|
artikel
|
| 39 |
Endothelial dysfunction in normoglycaemic first-degree relatives of type 2 diabetes mellitus complicated with hyperuricaemia
|
Zhang, Junxia
|
|
2017
|
|
2 |
p. 88-93
|
artikel
|
| 40 |
Evaluation of body adiposity index as a predictor of aortic stiffness in multi-ethnic Asian population with type 2 diabetes
|
Moh, Mei Chung
|
|
2015
|
|
2 |
p. 111-118
|
artikel
|
| 41 |
Exercise training: The under developed elixir vitae of chronic disease?
|
Ferguson, Carrie
|
|
2017
|
|
2 |
p. 113-115
|
artikel
|
| 42 |
Fibrinogen and future cardiovascular disease in people with diabetes: Aetiological associations and risk prediction using individual participant data from nine community-based prospective cohort studies
|
Kengne, Andre P
|
|
2013
|
|
2 |
p. 143-151
|
artikel
|
| 43 |
Gender-based divergence of cardiovascular outcomes in asymptomatic patients with type 2 diabetes: Results from the DIAD study
|
Tandon, Suman
|
|
2012
|
|
2 |
p. 124-130
|
artikel
|
| 44 |
Gerald Reaven: A man for our times
|
Handelsman, Yehuda
|
|
2019
|
|
2 |
p. 113-115
|
artikel
|
| 45 |
Global cardiovascular disease risk assessment in United States adults with diabetes
|
Wong, Nathan D
|
|
2012
|
|
2 |
p. 146-152
|
artikel
|
| 46 |
GLP-1 receptor agonists: A clinical perspective on cardiovascular effects
|
Mundil, Dhanwantee
|
|
2012
|
|
2 |
p. 95-108
|
artikel
|
| 47 |
Glycaemic control and restenosis after percutaneous coronary interventions in patients with diabetes mellitus: a report from the Insulin Diabetes Angioplasty study
|
Hage, Camilla
|
|
2009
|
|
2 |
p. 71-79
|
artikel
|
| 48 |
Glycaemic control by monoamine oxidase inhibition in a patient with type 1 diabetes
|
Emory, Hamlin
|
|
2017
|
|
2 |
p. 163-165
|
artikel
|
| 49 |
Glycaemic variation is a predictor of all-cause mortality in the Veteran Affairs Diabetes Trial
|
Zhou, Jin J
|
|
2019
|
|
2 |
p. 178-185
|
artikel
|
| 50 |
Guideline treatment results in regression of atherosclerosis in type 2 diabetes mellitus
|
Strang, Aart C
|
|
2015
|
|
2 |
p. 126-132
|
artikel
|
| 51 |
HDL cholesterol levels and weight are the main determinants of subclinical atherosclerosis in the young with type 1 diabetes and suitable glycaemic control
|
Pinto, Camila S
|
|
2014
|
|
2 |
p. 125-128
|
artikel
|
| 52 |
Heart failure and diabetes – underestimated, underdiagnosed and poorly understood: A call for action
|
Marx, Nikolaus
|
|
2017
|
|
2 |
p. 67-68
|
artikel
|
| 53 |
High-density lipoprotein impedes glycation of low-density lipoprotein
|
Younis, Nahla N
|
|
2013
|
|
2 |
p. 152-160
|
artikel
|
| 54 |
HOMA-beta in the UKPDS and ADOPT. Is the natural history of type 2 diabetes characterised by a progressive and inexorable loss of insulin secretory function? Maybe? Maybe not?
|
Reaven, Gerald M.
|
|
2009
|
|
2 |
p. 133-138
|
artikel
|
| 55 |
Hyperglycaemia and the SOAR stroke score in predicting mortality
|
McCall, Stephen J
|
|
2018
|
|
2 |
p. 114-121
|
artikel
|
| 56 |
Hypoglycaemia in patients with diabetes mellitus and renal impairment
|
Hettige, Thushan S
|
|
2017
|
|
2 |
p. 166-168
|
artikel
|
| 57 |
Impact of metabolic control on macular thickness in diabetic macular oedema
|
Peng, Yi-Jie
|
|
2018
|
|
2 |
p. 165-168
|
artikel
|
| 58 |
Impact of race/ethnicity on insulin resistance and hypertriglyceridaemia
|
Raygor, Viraj
|
|
2019
|
|
2 |
p. 153-159
|
artikel
|
| 59 |
Impacts of sodium-glucose co-transporter type 2 inhibitors on central blood pressure
|
Takenaka, Tsuneo
|
|
2018
|
|
2 |
p. 154-157
|
artikel
|
| 60 |
Impaired compensatory response to hypovolaemic circulatory stress in type 1 diabetes mellitus
|
Lindenberger, Marcus
|
|
2011
|
|
2 |
p. 136-142
|
artikel
|
| 61 |
Impaired hypoxic cerebral vasodilation in younger adults with metabolic syndrome
|
Harrell, John W
|
|
2013
|
|
2 |
p. 135-142
|
artikel
|
| 62 |
Impaired left ventricular function and myocardial blood flow reserve in patients with long-term type 1 diabetes and no significant coronary artery disease: Associations with protein glycation
|
Sveen, Kari Anne
|
|
2014
|
|
2 |
p. 84-91
|
artikel
|
| 63 |
Impaired olfactory function is related to the presence of neuropathy in adults with type 1 diabetes
|
Duda-Sobczak, Anna
|
|
2017
|
|
2 |
p. 139-143
|
artikel
|
| 64 |
Increased circulating levels of musclin in newly diagnosed type 2 diabetic patients
|
Chen, Wen-Jia
|
|
2017
|
|
2 |
p. 116-121
|
artikel
|
| 65 |
Increased plasma dipeptidyl peptidase-4 activities are associated with high prevalence of diabetic nephropathy in Chinese patients with newly diagnosed type 2 diabetes: A cross-sectional study
|
Zheng, Tianpeng
|
|
2016
|
|
2 |
p. 127-136
|
artikel
|
| 66 |
Increased prevalence of cardiovascular disease and risk biomarkers in patients with unknown type 2 diabetes visiting cardiology specialists: results from the DIASPORA study
|
Schöndorf, Thomas
|
|
2010
|
|
2 |
p. 145-150
|
artikel
|
| 67 |
Insulin resistance and insulin hypersecretion in the metabolic syndrome and type 2 diabetes: Time for a conceptual framework shift
|
Nolan, Christopher J
|
|
2019
|
|
2 |
p. 118-127
|
artikel
|
| 68 |
Insulin resistance: Impact on therapeutic developments in diabetes
|
Bailey, Clifford J
|
|
2019
|
|
2 |
p. 128-132
|
artikel
|
| 69 |
Insulin resistance: The linchpin between prediabetes and cardiovascular disease
|
Salazar, Martin R
|
|
2016
|
|
2 |
p. 157-163
|
artikel
|
| 70 |
Long-term effect of metformin on metabolic parameters in the polycystic ovary syndrome
|
Cheang, Kai I.
|
|
2009
|
|
2 |
p. 110-119
|
artikel
|
| 71 |
Mapping the methylation status of the miR-145 promoter in saphenous vein smooth muscle cells from individuals with type 2 diabetes
|
Riches, Kirsten
|
|
2017
|
|
2 |
p. 122-129
|
artikel
|
| 72 |
Netrin-1 promotes mesenchymal stem cell revascularization of limb ischaemia
|
Ke, Xianjin
|
|
2016
|
|
2 |
p. 145-156
|
artikel
|
| 73 |
Non-haemodynamic anti-anginal agents in the management of patients with stable coronary artery disease and diabetes: A review of the evidence
|
Ambrosio, Giuseppe
|
|
2016
|
|
2 |
p. 98-112
|
artikel
|
| 74 |
Non-invasive assessment of microcirculation by sidestream dark field imaging as a marker of coronary artery disease in diabetes
|
Djaberi, Roxana
|
|
2013
|
|
2 |
p. 123-134
|
artikel
|
| 75 |
Peroxisome proliferator-activated receptor (PPAR α/γ) agonists as a potential target to reduce cardiovascular risk in diabetes
|
Nicholls, Stephen J
|
|
2012
|
|
2 |
p. 89-94
|
artikel
|
| 76 |
Personal Memories
|
|
|
2019
|
|
2 |
p. 207-209
|
artikel
|
| 77 |
Phaseolamin treatment prevents oxidative stress and collagen deposition in the hearts of streptozotocin-induced diabetic rats
|
Oliveira, Renato JS
|
|
2014
|
|
2 |
p. 110-117
|
artikel
|
| 78 |
Pioglitazone: The forgotten, cost-effective cardioprotective drug for type 2 diabetes
|
DeFronzo, Ralph A
|
|
2019
|
|
2 |
p. 133-143
|
artikel
|
| 79 |
Prevalence and control of dyslipidaemia among diabetic patients with microalbuminuria in a Chinese hospital
|
Wang, Shao-hua
|
|
2013
|
|
2 |
p. 169-178
|
artikel
|
| 80 |
Prevalence and risk factors for peripheral artery disease in an Asian population with diabetes mellitus
|
Tavintharan, S.
|
|
2009
|
|
2 |
p. 80-86
|
artikel
|
| 81 |
Prevalence of type 2 diabetes is higher in peripheral artery disease than in coronary artery disease patients
|
Silbernagel, Guenther
|
|
2015
|
|
2 |
p. 146-149
|
artikel
|
| 82 |
Probing SGLT2 as a therapeutic target for diabetes: Basic physiology and consequences
|
Gallo, Linda A
|
|
2015
|
|
2 |
p. 78-89
|
artikel
|
| 83 |
Procoagulant activity in patients with combined type 2 diabetes and coronary artery disease: No effects of long-term exercise training
|
Bratseth, Vibeke
|
|
2017
|
|
2 |
p. 144-151
|
artikel
|
| 84 |
Promoter polymorphism at the tumour necrosis factor/lymphotoxin-alpha locus is associated with type of diabetes but not with susceptibility to sight-threatening diabetic retinopathy
|
Kaidonis, Georgia
|
|
2016
|
|
2 |
p. 164-167
|
artikel
|
| 85 |
Pulse pressure does not predict the response of diabetic nephropathy to glucose-lowering therapy
|
Nakhjavani, Manouchehr
|
|
2015
|
|
2 |
p. 150-151
|
artikel
|
| 86 |
Reduced endothelial activation after exercise is associated with improved HbA1c in patients with type 2 diabetes and coronary artery disease
|
Byrkjeland, Rune
|
|
2017
|
|
2 |
p. 94-103
|
artikel
|
| 87 |
Regional arterial stiffness in central and peripheral arteries is differentially related to endothelial dysfunction assessed by brachial flow-mediated dilation in metabolic syndrome
|
Badhwar, Smriti
|
|
2018
|
|
2 |
p. 106-113
|
artikel
|
| 88 |
Relationship between leisure-time physical activity and metabolic syndrome using varying definitions: 1999-2004 NHANES
|
Churilla, James R.
|
|
2009
|
|
2 |
p. 100-109
|
artikel
|
| 89 |
Relationships among insulin resistance, obesity, diagnosis of the metabolic syndrome and cardio-metabolic risk
|
Salazar, Martin R
|
|
2011
|
|
2 |
p. 109-116
|
artikel
|
| 90 |
Resistin increases platelet P-selectin levels via p38 MAPK signal pathway
|
Qiu, Wenbing
|
|
2014
|
|
2 |
p. 121-124
|
artikel
|
| 91 |
Response to `Insulin therapy in acute coronary syndromes'
|
de Mulder, Maarten
|
|
2009
|
|
2 |
p. 139-139
|
artikel
|
| 92 |
Response to Letter to the Editor entitled ‘Correct microarray analysis approaches in “Hsa-circRNA11783-2 in peripheral blood is correlated with coronary artery disease and type 2 diabetes mellitus”’
|
Zhao, Zhenzhou
|
|
2018
|
|
2 |
p. 169-170
|
artikel
|
| 93 |
Resveratrol ameliorates diabetic vascular inflammation and macrophage infiltration in db/db mice by inhibiting the NF-κB pathway
|
Guo, Rong
|
|
2014
|
|
2 |
p. 92-102
|
artikel
|
| 94 |
Reviewarticle: Asymmetric dimethylarginine as a mediator of vascular dysfunction and a marker of cardiovascular disease and mortality: an intriguing interaction with diabetes mellitus
|
Anderssohn, Maike
|
|
2010
|
|
2 |
p. 105-118
|
artikel
|
| 95 |
Reviewers for Diabetes and Vascular Disease Research: 2017
|
|
|
2018
|
|
2 |
p. 171-172
|
artikel
|
| 96 |
Role of myosin light chain and myosin light chain kinase in advanced glycation end product–induced endothelial hyperpermeability in vitro and in vivo
|
Wu, Fan
|
|
2016
|
|
2 |
p. 137-144
|
artikel
|
| 97 |
Safety and efficacy of saxagliptin added to thiazolidinedione over 76 weeks in patients with type 2 diabetes mellitus
|
Hollander, Priscilla L
|
|
2011
|
|
2 |
p. 125-135
|
artikel
|
| 98 |
Safety and efficacy of saxagliptin in combination with submaximal sulphonylurea versus up-titrated sulphonylurea over 76 weeks
|
Chacra, Antonio R
|
|
2011
|
|
2 |
p. 150-159
|
artikel
|
| 99 |
Serum potassium is an age-dependent risk factor for pre-diabetes and diabetes in the Israeli population
|
Doenyas-Barak, Keren
|
|
2014
|
|
2 |
p. 103-109
|
artikel
|
| 100 |
Serum sclerostin in vascular calcification and clinical outcome in chronic kidney disease
|
Zeng, Cong
|
|
2018
|
|
2 |
p. 99-105
|
artikel
|
| 101 |
SGLT-2 inhibitors and cardiovascular risk: Proposed pathways and review of ongoing outcome trials
|
Inzucchi, Silvio E
|
|
2015
|
|
2 |
p. 90-100
|
artikel
|
| 102 |
Sodium-glucose co-transporter inhibition in the treatment of diabetes: Sweetening the pot
|
Alvarez, Carlos A
|
|
2015
|
|
2 |
p. 74-77
|
artikel
|
| 103 |
SOS1 gene polymorphisms are associated with gestational diabetes mellitus in a Chinese population: Results from a nested case-control study in Taiyuan, China
|
Chen, Qiong
|
|
2018
|
|
2 |
p. 158-161
|
artikel
|
| 104 |
Statins and beyond: Concurrent strategies for prevention of cardiovascular disease in patients with type 2 diabetes
|
Standl, Eberhard
|
|
2013
|
|
2 |
p. 99-114
|
artikel
|
| 105 |
Stroke and cardiovascular morbidity and mortality associated with rosiglitazone use in elderly diabetic patients
|
Vanasse, Alain
|
|
2009
|
|
2 |
p. 87-93
|
artikel
|
| 106 |
Sub-optimal achievement of guideline-derived lipid goals in management of diabetes patients with atherosclerotic cardiovascular disease, despite high use of evidence-based therapies
|
DeGuzman, Pamela B
|
|
2012
|
|
2 |
p. 138-145
|
artikel
|
| 107 |
The advanced glycation end product methylglyoxal-derived hydroimidazolone-1 and early signs of atherosclerosis in childhood diabetes
|
Heier, Martin
|
|
2015
|
|
2 |
p. 139-145
|
artikel
|
| 108 |
The association between the metabolic syndrome and metabolic syndrome score and pulmonary function in non-smoking adults
|
Yoon, Hyun
|
|
2018
|
|
2 |
p. 131-138
|
artikel
|
| 109 |
The combined effect of vitamin D and parathyroid hormone concentrations on glucose homeostasis in older patients with prediabetes: A cross-sectional study
|
Karras, Spyridon N
|
|
2018
|
|
2 |
p. 150-153
|
artikel
|
| 110 |
The effect of intensive glucose control on all-cause and cardiovascular mortality, myocardial infarction and stroke in persons with type 2 diabetes mellitus: a systematic review and meta-analysis
|
Marso, Steven P.
|
|
2010
|
|
2 |
p. 119-130
|
artikel
|
| 111 |
The effects of rosiglitazone on myocardial triglyceride content in patients with type 2 diabetes: A randomised, placebo-controlled trial
|
McGavock, Jonathan
|
|
2012
|
|
2 |
p. 131-137
|
artikel
|
| 112 |
The metabolites in peripheral blood mononuclear cells showed greater differences between patients with impaired fasting glucose or type 2 diabetes and healthy controls than those in plasma
|
Kim, Minjoo
|
|
2017
|
|
2 |
p. 130-138
|
artikel
|
| 113 |
The predictive value of inflammatory activity and markers of the adipo-insular axis on restenosis in patients with type 2 diabetes
|
Hage, Camilla
|
|
2011
|
|
2 |
p. 143-149
|
artikel
|
| 114 |
The Reaven syndrome: An historical perspective
|
Soran, Handrean
|
|
2019
|
|
2 |
p. 116-117
|
artikel
|
| 115 |
The synthetic GLP-I receptor agonist, exenatide, reduces intimal hyperplasia in insulin resistant rats
|
Murthy, Subramanyam N.
|
|
2010
|
|
2 |
p. 138-144
|
artikel
|
| 116 |
Tick-tock: Is your cardiometabolic risk on the clock?
|
Stöhr, Robert
|
|
2014
|
|
2 |
p. 66-74
|
artikel
|
| 117 |
Type 1 diabetic patients have better endothelial function after simultaneous pancreas–kidney transplantation than after kidney transplantation with continued insulin therapy
|
Ziaja, Jacek
|
|
2018
|
|
2 |
p. 122-130
|
artikel
|
| 118 |
Vessel-specific rate of vasorelaxation is slower in diabetic rats
|
Murias, Juan M
|
|
2013
|
|
2 |
p. 179-186
|
artikel
|
| 119 |
Waist circumference is a strong and independent determinant of the distribution of HDL subfractions in overweight patients with cardiovascular risk factors
|
Rosenbaum, David
|
|
2012
|
|
2 |
p. 153-159
|
artikel
|
Tijdschrift beschrijving